摘要
背景:骨质疏松症是一个全球健康问题,导致骨强度降低,增加容易骨折。葛根素,从葛根中提取的植物雌激素(Willd)。Ohwi,已被确认为一种很有前途的干预对预防骨质疏松、促进骨再生。然而,其合成代谢作用的潜在机制仍不清楚。在目前的研究中,我们旨在探讨葛根素对成骨分化的骨髓基质细胞(bmsc)及其可能的分子机制协调行动。 方法:骨髓基质细胞(bmsc)和胃内的政府对切除卵巢的老鼠(OVX)被用来研究anti-osteoporotic葛根素的函数。增殖作用的参与蛋白激酶(MAPK)信号通路。 结果:我们的研究结果表明,在最佳浓度,葛根素能促进bmsc体外成骨分化。这种感应是MAPK信号通路介导的。进一步的详细研究表明,ERK1/2-Runx2信号通路的影响更加突出比p38信号通路puerarin-induced bmsc向成骨表型的分化。我们还发现葛根素防止骨矿物质密度减少和改善股骨骨小梁结构切除卵巢的老鼠。 结论:我们的研究结果揭示了葛根素的功能机制在促进成骨分化涉及ERK1/2和p38-MAPK途径并提供实验证据为葛根素的潜在应用雌激素替代疗法的骨质疏松症。
关键词: 葛根、骨质疏松症、骨髓基质细胞
Current Molecular Medicine
Title:Puerarin Stimulates Osteogenic Differentiation and Bone Formation Through the ERK1/2 and p38-MAPK Signaling Pathways
Volume: 17 Issue: 7
关键词: 葛根、骨质疏松症、骨髓基质细胞
摘要: Background: Osteoporosis is a world-wide health problem, which leads to decreased bone strength and increased susceptibility to fractures. Puerarin, a phytoestrogen extracted from Pueraria lobata (Willd.) Ohwi, has been identified as a promising intervention for preventing bone loss and promoting bone regeneration. However, the underlying mechanisms for its anabolic action are still not clear. In the present study, we aimed to investigate the effect of puerarin on the osteogenic differentiation of bone marrow stromal cells (BMSCs) and the possible molecular mechanism mediating its action.
Methods: Bone marrow stromal cells (BMSCs) and intragastric administration on ovariectomized(OVX) rats were used to study the anti-osteoporotic function of puerarin. The involvement of mitogen-activated protein kinase (MAPK) signaling pathways was determined.
Results: Our results demonstrated that at optimal concentration, puerarin could promote osteogenic differentiation of BMSCs in vitro. This induction was mediated by MAPK signaling pathway. Further detailed study revealed that ERK1/2-Runx2 signaling pathway had more prominent effect than p38 signaling pathway in puerarin-induced differentiation of BMSCs toward the osteogenic phenotype. We also found that puerarin protected against reduction in bone mineral density and improved femur trabecular bone structure in ovariectomized rats.
Conclusion: Our findings revealed the functional mechanism of puerarin in promoting osteogenic differentiation which involved ERK1/2 and p38-MAPK pathway and provided experimental evidence for the potential application of puerarin for estrogen replacement therapy of osteoporosis.
Export Options
About this article
Cite this article as:
Puerarin Stimulates Osteogenic Differentiation and Bone Formation Through the ERK1/2 and p38-MAPK Signaling Pathways, Current Molecular Medicine 2017; 17 (7) . https://dx.doi.org/10.2174/1566524018666171219101142
DOI https://dx.doi.org/10.2174/1566524018666171219101142 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
AMPK - Activated Protein Kinase and its Role in Energy Metabolism of the Heart
Current Cardiology Reviews A Review of IGF1 Signaling and IGF1-related Long Noncoding RNAs in Chemoresistance of Cancer
Current Cancer Drug Targets Type 2 Diabetes: An Atherothrombotic Syndrome
Current Molecular Medicine Autologous Mesenchymal Stem Cell Therapy in Progressive Multiple Sclerosis: An Open Label Study
Current Stem Cell Research & Therapy Editorial Statins: [Hot Topic: Statins: Effects Beyond Cholesterol Lowering (Guest Editor: Garry X. Shen)]
Current Drug Targets - Cardiovascular & Hematological Disorders Anti-Inflammatory Effects of Fibrates: An Overview
Current Medicinal Chemistry Metabolism and Pharmacological Mechanisms of Active Ingredients in <i>Erigeron breviscapus</i>
Current Drug Metabolism Novel Carriers for Coenzyme Q10 Delivery
Current Drug Delivery What Changes we may Expect in 2010 Hypertension Diagnosis and Management: Insights from the European Update Document
Current Vascular Pharmacology Enzymatic Processing of <i>Omega</i> 3 Long Chain Polyunsaturated Fatty Acid Oils
Current Nutrition & Food Science New Copper Compounds with Antiplatelet Aggregation Activity
Medicinal Chemistry Discovery of New Cardiovascular Hormones for the Treatment of Congestive Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Nanomedicine for Gene Delivery for the Treatment of Cardiovascular Diseases
Current Gene Therapy Cold Virus Fusion or Stopping Fusion Cold – Inhibitors of the Human Respiratory Syncytial Virus F Protein
Recent Patents on Anti-Infective Drug Discovery Intramolecular Processes and Their Applications in Prodrugs Approaches- Experimental and Computational Studies
Current Organic Chemistry Plasminogen Activator System and Vascular Disease
Current Vascular Pharmacology The Many Roles of Statins in Ischemic Stroke
Current Neuropharmacology Effective Agents Targeting the Mitochondria and Apoptosis to Protect the Heart
Current Pharmaceutical Design Transcatheter Aortic Valve Implantation Infective Endocarditis: Current Data and Implications on Prophylaxis and Management
Current Pharmaceutical Design Targeting miRNAs for Drug Discovery: A New Paradigm
Current Molecular Medicine